A meta-analysis of 22 randomized trials comparing drug-eluting stents and bare-metal stents showed no evidence of an increase in the risk of death, myocardial
The Dual Antiplatelet Therapy after drug-eluting stent implantation in ST-elevation MI (DAPT-STEMI) trial was designed to show that limiting DAPT to 6 months in
The first trial was called Correlation of Clopidogrel Therapy Discontinuation in Real-World Patients Treated with Drug-Eluting Stent Implantation and Late Coronary
While current clinical practice guidelines recommend a minimum of only 1 month of dual antiplatelet therapy (DAPT) after bare metal stent (BMS) placement
2015; 65:805–815
Read to know more